var path='https://www.tickertech.net'; function heading(heading) { document.write('
'+heading+' |
'+ ''+ ' |
'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('4/24 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose | \n'); } if (allow) { document.write('
4/16 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Amneal Launches PEMRYDI RTU, the First Ready-to-Use Version of Important Oncology Injectable Medicine | \n'); } if (allow) { document.write('
4/10 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Amneal to Report First Quarter 2024 Results on May 3, 2024 | \n'); } if (allow) { document.write('
3/28 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Amneal to Ring the Nasdaq Closing Bell on April 2, 2024 | \n'); } if (allow) { document.write('
3/25 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension | \n'); } if (allow) { document.write('
3/1 - 6:00 AM \; \; | \n'); } if (allow) { document.write('Amneal Reports Fourth Quarter and Full Year 2023 Financial Results | \n'); } if (allow) { document.write('
2/27 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203 | \n'); } if (allow) { document.write('
2/13 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Amneal to Participate at Upcoming Investor Conference | \n'); } if (allow) { document.write('
2/8 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Amneal Announces Complete Response Resubmission for IPX203 New Drug Application | \n'); } if (allow) { document.write('
2/1 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Deb Autor, Former FDA Deputy Commissioner, Appointed CEO of Healthcare Innovation Catalysts | \n'); } if (allow) { document.write('
1/31 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Amneal to Report Fourth Quarter and Full Year 2023 Results on March 1, 2024 | \n'); } if (allow) { document.write('
1/25 - 7:30 AM \; \; | \n'); } if (allow) { document.write('Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203 | \n'); } if (allow) { document.write('
1/10 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension | \n'); } if (allow) { document.write('
1/8 - 8:01 AM \; \; | \n'); } if (allow) { document.write('INVESTIGATION ALERT: Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (NYSE: AMRX) and Encourages Long-Term Investors to Contact the Firm | \n'); } if (allow) { document.write('
1/4 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Amneal Launched Record Number of 39 New Retail and Injectable Products in 2023, Including 13 in Q4 2023 | \n'); } if (allow) { document.write('
\n'); } if (allow) { document.write(' |